UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - vaithilingaraja+arumugaswami
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2020-919-4 COVID 19 CELL MODEL SYSTEMS AND ANTIVIRAL AGENTS
SUMMARY: Researchers from UCLA’s Department of Molecular and Medical Pharmacology in collaboration with external collaborators have developed a platform for complex testing of antiviral agents in multiple cell models. Currently this technology is optimized for Coronavirus-type strains, but the system can easily be adapted to other viral pathogens....
Published: 9/12/2023
|
Inventor(s):
Vaithilingaraja Arumugaswami
Keywords(s):
Category(s):
Life Science Research Tools > Research Methods
,
Life Science Research Tools
,
Diagnostic Markers > Targets And Assays
,
Therapeutics > Infectious Diseases
2020-940 USE OF MTORC1 INHIBITORS TO TREAT COVID-19
UCLA researchers in the Department of Biological Chemistry have implicated a novel marker in SARS-CoV-2 infection, identifying a novel drug target for therapeutics treating COVID-19.BACKGROUNDSevere acute respiratory syndrome coronavirus-2, or SARS-CoV-2, is the virus responsible for the 2019 global pandemic (COVID-19): which caused hundreds of millions...
Published: 9/5/2023
|
Inventor(s):
Heather Christofk
,
Peter Mullen
,
Vaithilingaraja Arumugaswami
Keywords(s):
Therapeutics & Vaccines
Category(s):
Therapeutics
2019-880 ZIKA VIRUS-BASED ONCOLYTIC THERAPY FOR BRAIN CANCER
UCLA researchers in the Department of Molecular and Medical Pharmacology have developed a novel zika virus-based oncolytic therapy to treat brain cancer.BACKGROUND: Glioma is a type of brain tumor that accounts for 80% of all primary malignant brain tumors. Standard therapy for high-grade glioma requires a combination of surgical resection, radiation...
Published: 9/12/2023
|
Inventor(s):
Vaithilingaraja Arumugaswami
,
David Nathanson
Keywords(s):
Cns
,
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Immunology
,
Immunotherapy
,
Oncology
,
Oncology Immunotherapy
,
Plasmids / Vectors
,
Therapeutics & Vaccines
,
Viral Delivery Systems
Category(s):
Diagnostic Markers > Immunology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Vaccines
,
Therapeutics > Oncology
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Oncology > Oncology Immunotherapy
2020-806 SMALL MOLECULE DRUGS FOR CORONAVIRUS INFECTIONS
UCLA researchers in the Department of Molecular and Medical Pharmacology have discovered a group of small molecule compounds that are active against live SARS-CoV-2 at therapeutically relevant concentrations.BACKGROUND: COVID-19 is a global pandemic caused by a newly discovered coronavirus, severe acute respiratory syndrome-related coronavirus (SARS-CoV-2)....
Published: 9/12/2023
|
Inventor(s):
Vaithilingaraja Arumugaswami
,
Robert Damoiseaux
Keywords(s):
Infectious Diseases
,
Therapeutics & Vaccines
Category(s):
Therapeutics > Infectious Diseases
Multilayer Batch Microfabricated Magnetic Shielding
UCLA Case No. 2018-014 SUMMARYUCLA researchers in the Department of Electrical Engineering have developed a novel batch microfabrication technique for microscale shielding layers, simultaneously pushing the limits of minimum size, maximum shielding factor, flexibility, and cost.BACKGROUNDCompact electromagnetic shielding paves the way for a new generation...
Published: 7/19/2023
|
Inventor(s):
Robert Candler
,
Jimmy Chen-Yen Wu
,
Ling Li
,
Jere Harrison
Keywords(s):
Electronics & Semiconductors
Category(s):
Electrical > Electronics & Semiconductors
,
Materials > Fabrication Technologies